Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma

Table 2

Pre-LT imaging and explant tumor characteristics.

	Sorafenib adjuvant therapy 𝑛=7		Historical comparison group 𝑛=12
	Imaging	Explant	Imaging	Explant
Tumor 𝑁 > 3	0	3 (42.8%)	0	6 (50%)
Maximum tumor size (cm)	5.5	8	8	7
Mean tumor diameter (cm)	2.86 (1.34)	3.90 (2.12)	3.38 (1.84)	3.75 (1.59)
Vascular invasion	0	2 (28.5%)	0	4 (33%)
Histological grade**
Well/moderate		3		4
Poor		4		8

𝑃 values between groups not significant and not reported.
**Modified Edmondson criteria [16].